MA45867B1 - Estrogen receptor modulators - Google Patents

Estrogen receptor modulators

Info

Publication number
MA45867B1
MA45867B1 MA45867A MA45867A MA45867B1 MA 45867 B1 MA45867 B1 MA 45867B1 MA 45867 A MA45867 A MA 45867A MA 45867 A MA45867 A MA 45867A MA 45867 B1 MA45867 B1 MA 45867B1
Authority
MA
Morocco
Prior art keywords
estrogen receptor
receptor modulators
compounds
processes
formula
Prior art date
Application number
MA45867A
Other languages
French (fr)
Inventor
Bernard Barlaam
James Scott
Thomas Moss
Samantha Hughes
Johannes Nissink
Bin Yang
Original Assignee
Astrazeneca Ab 151 85 Soedertaelje
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab 151 85 Soedertaelje filed Critical Astrazeneca Ab 151 85 Soedertaelje
Priority claimed from PCT/EP2018/052040 external-priority patent/WO2018138303A1/en
Publication of MA45867B1 publication Critical patent/MA45867B1/en

Links

Landscapes

  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des composés de formule (i) : (i) et leurs sels pharmaceutiquement acceptables, des procédés et des intermédiaires utilisés pour leur préparation, des compositions pharmaceutiques les contenant ainsi que leur utilisation dans le traitement de troubles de prolifération cellulaire.The present invention relates to compounds of formula (i): (i) and their pharmaceutically acceptable salts, processes and intermediates used for their preparation, pharmaceutical compositions containing them as well as their use in the treatment of cell proliferation disorders.

MA45867A 2017-01-30 2018-01-29 Estrogen receptor modulators MA45867B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762451971P 2017-01-30 2017-01-30
PCT/EP2018/052040 WO2018138303A1 (en) 2017-01-30 2018-01-29 Estrogen receptor modulators

Publications (1)

Publication Number Publication Date
MA45867B1 true MA45867B1 (en) 2020-01-31

Family

ID=66669170

Family Applications (1)

Application Number Title Priority Date Filing Date
MA45867A MA45867B1 (en) 2017-01-30 2018-01-29 Estrogen receptor modulators

Country Status (3)

Country Link
AR (1) AR110788A1 (en)
HR (1) HRP20192220T1 (en)
MA (1) MA45867B1 (en)

Also Published As

Publication number Publication date
AR110788A1 (en) 2019-05-02
HRP20192220T1 (en) 2020-03-06

Similar Documents

Publication Publication Date Title
MA40111B1 (en) Derivatives of tetrahydronaphthalene inhibiting mcl-1 protein
MA37762B1 (en) N-aryltriazole compounds used as antagonists of lpar
MA37764A1 (en) N-alkyltriazole compounds used as antagonists of lpar
MA40225B1 (en) Substituted dihydroisoquinolinone compounds
MA50240B1 (en) Cystic fibrosis transmembrane conductance regulatory protein modulators and methods of use
MA39211B1 (en) Tricyclic compounds as anti-cancer agents
MA46101B1 (en) Positive allosteric modulators of the m1 muscarinic receptor
MA31419B1 (en) PYRIDINE DERIVATIVES
MA33533B1 (en) Pharmaceutical formulations for the treatment of cancer and other diseases or disorders
MA49127B1 (en) N-substituted indole derivatives
MA37765A1 (en) Substituted pyrazole compounds used as lpar antagonists
MA34545B1 (en) CO-CRYSTALS AND SALTS OF CCR3 INHIBITORS
MA43913A (en) POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC M1 RECEPTOR
MA46229B1 (en) Heteroaryl carboxamide compounds as inhibitors of ripk2
MA35932B1 (en) Pyrazolopyrimidinyl inhibitors of the ubiquitin activating enzyme
MA43052B1 (en) Human Plasma Kallikrein Inhibitors
MA31863B1 (en) PYRAZOLE DERIVATIVES AS 5-LO INHIBITORS
MA44965A (en) PYRIDINYL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES OF THEM AS AOC3 INHIBITORS
MA39253B1 (en) Substituted bicyclic heteroaryl compounds used as rxr agonists
MA39750A (en) AZA-INDOL-ACETIC ACID DERIVATIVES AND THEIR USE AS MODULATORS OF PROSTAGLANDIN D2 RECEPTOR
MA39229A1 (en) Pyrrolidines, terrahydrofurans and substituted cyclopentanes useful as orexin receptor antagonists
MA53372B1 (en) Pyridopyrimidinenes as histamine h4 receptor inhibitors
MA45867B1 (en) Estrogen receptor modulators
MA56098B1 (en) HETEROCYCLIC IMMUNOMODULATORS AS WELL AS PDL1 INHIBITORS
MA56854B1 (en) TRICYCLIC AKR1C3-DEPENDENT KARS INHIBITORS